Caremed Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 05-12-2024
- Paid Up Capital ₹ 0.10 M
as on 05-12-2024
- Company Age 8 Year, 5 Months
- Last Filing with ROC 31 Mar 2021
- Revenue %
(FY 2021)
- Profit 53.11%
(FY 2021)
- Ebitda 36.44%
(FY 2021)
- Net Worth -1.84%
(FY 2021)
- Total Assets -0.06%
(FY 2021)
About Caremed Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Prasad Sali, Vasudevarao Kadarabad, Raghunath Khade, and Three other members serve as directors at the Company.
- CIN/LLPIN
U85122MH2016PTC283689
- Company No.
283689
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Jul 2016
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Caremed Healthcare?
Board Members(6)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Prasad Sali | Director | 08-Dec-2016 | Current |
Vasudevarao Kadarabad | Director | 08-Dec-2016 | Current |
Raghunath Khade | Director | 08-Dec-2016 | Current |
Deepak Pandurang | Director | 08-Dec-2016 | Current |
Tarun Katiyar | Director | 15-Jul-2016 | Current |
Rajesh Katiyar | Director | 15-Jul-2016 | Current |
Financial Performance of Caremed Healthcare.
Caremed Healthcare Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 53.11% increase in profit. The company's net worth dipped by a decrease of 1.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Caremed Healthcare?
In 2021, Caremed Healthcare had a promoter holding of 20.00% and a public holding of 80.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Hospaccx Healthcare Business Consulting Private LimitedActive 10 years 11 months
Tarun Katiyar and Rajesh Katiyar are mutual person
- Phalguni Healthcare Private LimitedActive 13 years 9 months
Vasudevarao Kadarabad is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Caremed Healthcare?
Unlock and access historical data on people associated with Caremed Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Caremed Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Caremed Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.